PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummarySep 3, 2015	Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V. PLAINSBORO, N.J. and AMSTERDAM, The Netherlands, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris® and	View HTML Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V. 19.9 KB
Toggle SummarySep 1, 2015	Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion PLAINSBORO, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. "We are pleased to improve our overall capital structure by expanding the size of	View HTML Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion 12.1 KB
Toggle SummaryAug 26, 2015	Integra LifeSciences to Present at the Wells Fargo 2015 Healthcare Conference and the 2015 Morgan Stanley Global Healthcare Conference in September PLAINSBORO, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in September: At 10:20AM ET on Thursday, September 10, 2015, Mr. Glenn Coleman, Chief Financial Officer, will present at the	View HTML Integra LifeSciences to Present at the Wells Fargo 2015 Healthcare Conference and the 2015 Morgan Stanley Global Healthcare Conference in September 10.6 KB
Toggle SummaryAug 25, 2015	Integra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) Results Accepted for Publication in Wound Repair and Regeneration	View HTML Integra LifeSciences Announces FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra(R) Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) 17.4 KB
Toggle SummaryAug 4, 2015	Integra LifeSciences Prices Public Offering of Common Stock PLAINSBORO, N.J., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has priced its previously announced underwritten public offering of 3,300,000 shares of its common stock at $61.00 per share.	View HTML Integra LifeSciences Prices Public Offering of Common Stock 14.1 KB
Toggle SummaryAug 3, 2015	Integra LifeSciences Announces Proposed Public Offering of Common Stock PLAINSBORO, N.J., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer, subject to market conditions and other factors, $200,000,000 of its common stock in an underwritten public offering registered under the Securities	View HTML Integra LifeSciences Announces Proposed Public Offering of Common Stock 14 KB
Toggle SummaryJul 30, 2015	Integra LifeSciences Reports Second Quarter 2015 Financial Results Revenue Increased 5.5% to $244.1 Million Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79 Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART)	View HTML Integra LifeSciences Reports Second Quarter 2015 Financial Results 47 KB
Toggle SummaryJul 20, 2015	Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical PLAINSBORO, N.J., July 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ("TEI"). "We are enthusiastic about the strategic fit of	View HTML Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical 12.7 KB
Toggle SummaryJul 15, 2015	Integra LifeSciences to Host Its Second Quarter 2015 Earnings Results Conference Call on July 30, 2015 PLAINSBORO, N.J., July 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2015 financial results on Thursday, July 30, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Second Quarter 2015 Earnings Results Conference Call on July 30, 2015 10.1 KB
Toggle SummaryJul 1, 2015	Integra LifeSciences Completes Spin-Off of SeaSpine PLAINSBORO, N.J., July 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has completed the previously announced tax-free spin-off of its orthobiologics and spinal fusion hardware business, now known as SeaSpine Holdings Corporation	View HTML Integra LifeSciences Completes Spin-Off of SeaSpine 10 KB